Product Image

Melatonin 1 mg

NaturesPlus
4.7
★ ★ ★ ★ ★
(503 ratings)
Melatonin 1 mg
Product Image
Score84
A focused, low-dose melatonin tablet with strong value and transparent labeling. Its standard delivery is best for sleep onset rather than maintenance.
How scoring works
Quantity:90 Tablet(s) • (90 servings)
Goals:
Sleep Support

Score 84

A focused, low-dose melatonin tablet with strong value and transparent labeling. Its standard delivery is best for sleep onset rather than maintenance.
How scoring works
$6.33($0.07 per serving)
Vitacost
$ 6.33
Pure Formulas
$ 6.33
iHerb
$ 6.33
Report prices

Analysis

A 1 mg melatonin amount supports circadian timing and sleep onset with good dose restraint. It is a sensible starting range for many users who want to avoid unnecessary strength.

The single active is fully disclosed, and one tablet provides the complete serving. A hard tablet may act less quickly than dissolving formats and offers no extended delivery for nighttime waking.

Low cost and simple dosing strengthen everyday practicality when melatonin is appropriate. Sensitive users should still check for morning drowsiness or vivid dreams before making it part of a regular routine.

Who is it for
  • Adults starting with a low melatonin dose
  • Value-conscious users
  • People focused on circadian timing
Best for
  • Sleep-onset support
  • Schedule shifts and jet lag
  • Simple low-dose routines

Pros

  • Clearly disclosed 1 mg amount
  • Strong qualitative value
  • Simple single-tablet serving

Cons

  • No sustained-release support
  • Hard tablet may act less quickly than dissolving formats
  • Covers only one sleep pathway

Warnings

  • Melatonin may cause drowsiness or vivid dreams in sensitive users
  • Avoid driving until personal response is known
  • Taking it too late may affect morning alertness

Nutrient quality

88 Highest impact

The conservative melatonin amount provides precise sleep-onset support with little overdose concern. Basic tablet delivery adds no specialized onset or maintenance support.

.

Ingredient transparency

82 Highest impact

Active amounts and the basic serving format are clear without hidden blends. Full directions, source purity, and inactive ingredients remain incomplete.

.

Customer satisfaction

66 High impact

The supplied aggregate satisfaction signal is favorable and has some support from its response volume. Specific experience details are absent, so complaint patterns and purpose fit cannot be confirmed.

.

Value for money

98 Highest impact

The dose, format, and serving value make the product competitively positioned. Only incomplete purity or excipient detail limits the comparison.

.
Report analysis

Goals

Sleep Support
Impact
Highest effect
A+ Goal FitA Strength of SupportB- CoverageA+ Formula Quality
Melatonin · 1 mg

A clearly disclosed low melatonin dose is closely aligned with sleep onset and circadian timing. Melatonin has strong human evidence for these specific uses.

The single-ingredient formula is focused and avoids conflicting actives. Its standard hard tablet may act less quickly than rapid-release formats and offers no sustained-release support for nighttime awakenings.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Melatonin
1 mg
Gluten Free Adults 18–50 Vegan Dairy Free No Allergies Vegetarian
Report overview
Melatonin · 1 mg OverallScore68
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The hard tablet may act more slowly and provides no sustained-release support. A single tablet clearly supplies 1 mg within the physiological range. Very low serving cost offers good value, though no independent purity certification is disclosed.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  3. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  4. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  5. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  6. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin